Company: IXHL
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001213900-25-036057
Chunk: 33

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 33
---
 to the discretion of the board of directors, we will file the Certificate of Amendment to our Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware as soon as practicable. As of April 21, 2025, of our 100,000,000 authorized shares, 27,546,753shares of our common stock were issued and outstanding, an additional approximately 6,238,112shares were reserved for issuance under our various stock -basedplans and awards granted thereunder or upon the exercise of outstanding options and warrants (other than the Warrants issued in the Private Placement), seven shares of our common stock are reserved for issuance under our April 7, 2025 at -the -marketoffering Sales Agreement with A.G.P./Alliance Global Partners and the remaining approximately 66,215,128 of our authorized shares were reserved for issuance upon the exercise of the Warrants issued in the Private Placement. Accordingly, no shares of common stock are available for future purposes or issuances. As of the closing of the Private Placement on March 10, 2025, we issued Pre -FundedWarrants to purchase up to 1,887,045shares of our common stock and Series A Warrants to purchase up to 11,574,090shares of our common stock. Assuming full adjustment of the exercise price equal to the Floor Price of $0.216 per share and exercise pursuant to the zero exercise price provisions, the exercise of the Series A Warrants would result in the issuance of up to 347,222,700shares of our common stock. An increase in the authorized shares of common stock is necessary to allow for the issuance of the Series A Warrant Shares and we are required to seek approval for this increase pursuant to the terms of the Series A Warrants. Both Proposal Nos. 1 and 2 must be approved in order for the Series A Warrants to become exercisable upon completion of the Special Meeting. In addition, approval of this Proposal No. 2 and the filing of the Certificate of Amendment to our Amended and Restated Certificate of Incorporation contemplated hereby would allow us to have enough authorized shares of our common stock to effect the Amended 2023 Plan if approved in Proposal No. 3. Approval of Proposal No. 4 (the Reverse Stock Split Proposal) and filing of the Certificate of Amendment to our Amended and Restated Certificate of Incorporation contemplated thereby (at a reverse stock split ratio at or greater than